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Abstract
Insulin-like growth factor binding protein-2 (IGFBP-2) is the largest member of a
family of six proteins (IGFBP-I to 6) that bind insulin-like growth factors-I and -II
(IGF-VII) with high affinities. IGFBP molecules contain three domains of
approximately equal length: the conserved cysteine-rich amino- and carboxyl-terminal
domains, which are joined by a vanable linker domain. The C-terminal domains of
IGFBPs not only contribute to high-affinity IGF binding, but also confer binding
specificity and have overlapping but variable interactions with many other molecules.
At the time this project commenced, there was limited information on the structure-
function relationships of the C-domain of IGFBPs.
In this thesis, the foilowing N- and C-domain fragments were prepared in
sufficient quantities for NMR studies: unlabelled, ttN-labelled and 1sN/13c-1abe11ed 183-
'SeIGFBP-2 (C-BP-2), unlabelled 141-28eIGFBP -2 (Large-C-BP-2), and unlabelled and
t5N-1abe11ed t-t38IGFBP-2 
G\f-BP-2). The IGF binding abilities of these fragments were
assessed using BIAcore and cross-linking methods. Overall, the results indicated that
C-BP-2 binds IGFs to only a limited extent, although the differences in IGF binding
affinities among C-BP-2, N-BP-2 and full-length IGFBP-2 appeared to be larger in
cross-linking studies than in BIAcore experiments.
The solution structure of C-BP-2 was determined using NMR spectroscopy. C-BP-
2 has a tþroglobulin type 1 fold comprising an o-helix, a three-stranded anti-parallel
B-sheet and three flexible loops. Compared to the structures of C-BP-6 (Headey et a1.,
2004a), C-BP-I (Sala et aI.,2005) and C-BP-4 (Sitar et at,2006), which were reported
during the course of the current study, the following structural differences that may
affect IGF binding and have implications for other functional differences were found:
C-BP-2 has (i) a longer disordered loop I, and (ii) an extended C-terminal tail, which is
unstructured and very mobile. (iii) The length of the helix is identical to that of C-BP-6
but shorter than that of C-BP-1. (iv) An RGD motif is located in a solvent-exposed tum.
The backbone dynamics of C-BP-2 were anaþsed using the reduced spectral density
mapping approach based on the measured backbone amide 1sN relaxation parameters
(Rt, Rz and steady-state 15N-{1H} NOE), and the results were compared to the dynamic
properties of C-BP-6 (Yao et a1.,2004). C-BP-2 possesses significant fast time-scale
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motions in the loops and termini, and may also have slow time-scale conformational or
chemical exchange in the structured domain core and the loop II.
A more complete set of assignments for IGF-I tH-ttN HSQC spectra was obtained.
The IGF and N-BP-2 binding sites on C-BP-2 were identified by NMR. Binding of C-
BP-2 to the IGF'N-BP-2 binary complexes was significantly stronger than the binding
of C-BP-2 to IGFs alone, switching from intermediate exchange to slow exchange,
indicating there is cooperativity between N-BP-2 and C-BP-2 in IGF binding. Two
possible structural mechanisms for this cooperativity were found: a possible
conformational change of the Phe49-Leu54 region and the sidechain aromatic ring of
Phe49 in IGF-I, and direct interaction between the N- and C-domains.
A pH-dependent heparin binding site on C-BP-2 was also identified by NMR. The
heparin binding site is a patch containing the B-turn connecting the first and second
strands, part of the third strand, and the beginning of the C-terminal IalI. Lys227,
His228, Asn232,Lev233,Lys234 andHis2TI are proposed to be the primary heparin
binding residues. Protonation of His271 and His228 seems to be important for the
binding, which occurs at slightly acidic pH (6.0) and is more significant at pH 5.5, but
is largely suppressed at pH 7.4. Possible preferential binding of IGFBP-2 and its C-
domain fragments to glycosaminoglycans in the acidic extracellular matrix of tumours
may be related to their roles in cancer.
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